Open access resources and a peer review example for the future of science
Nobel prize winning CRISPR technology to be applied in development of genetically engineered cell and animal models
License to Nobel prize-winning CRISPR technology supports internal research and development
ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models
License allows Cell Guidance Systems to use Lightning-Link® in manufacture of TRIFic™ exome detection immunoassay kits
ERS Genomics Limited and DefiniGEN Ltd announced a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents
Isogenica has granted a licence to Aro to utilize its proprietary in vitro CIS Display technology
Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents
Advances enhance performance of mass spectrometers.
The license enables SAGE Labs to use the CRISPR/Cas9 system to engineer cell and animal models for their clients as well as distribute validated CRISPR reagents.